We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet (BrainProtein)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02614599
Recruitment Status : Completed
First Posted : November 25, 2015
Last Update Posted : April 8, 2021
Sponsor:
Collaborators:
PronoKal Foundation
Child Health Foundation
Information provided by (Responsible Party):
Spanish Foundation for Neurometrics Development

Tracking Information
First Submitted Date  ICMJE April 22, 2013
First Posted Date  ICMJE November 25, 2015
Last Update Posted Date April 8, 2021
Study Start Date  ICMJE June 2015
Actual Primary Completion Date November 2015   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: November 21, 2015)
Changes Related Potential Recording after 3 months of dietary approach [ Time Frame: 3 months ]
Evaluate changes in reaction time, omission and comission errors, latencies and amplitudes in brainwaves during visual continuous performance task from 19 channels EEG recordings, before begin nutritional measures and after 3 months of dietary approach.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: November 21, 2015)
  • Quantitative Electroencephalogram [ Time Frame: 3 months ]
    Analysis frequencies and amplitudes of brainwaves and spectral independent components before and after 3 months of nutritional intervention
  • Behavior [ Time Frame: 3 months ]
    Evaluate Behavior with clinical scales (AMEN questionnaire) at the beginning and after 3 months of nutritional approach.
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures
 (submitted: November 21, 2015)
  • Change in Weight [ Time Frame: 3 months ]
    Change from Baseline in Weight after 3 months of nutritional intervention
  • Change in body mass index [ Time Frame: 3 months ]
    Change in body mass index after 3 months of nutritional intervention.
  • Change in body composition [ Time Frame: 3 months ]
    Change in body composition using bioelectrical impedance after 3 months of nutritional intervention.
  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability [ Time Frame: From April to December 2013 ]
    Number of Participants with Adverse Events as a Measure of Safety and Tolerability of Brain Proteins Supplements
Original Other Pre-specified Outcome Measures Same as current
 
Descriptive Information
Brief Title  ICMJE Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet
Official Title  ICMJE Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein
Brief Summary Multicenter, Prospective, randomized, comparative and controlled study about the beneficial effects in behavior and brain connectivity of different dietary patterns in 100 children with ADHD between 7 and 12 years, followed up for 3 months of nutritional therapy.
Detailed Description We collect electroencephalogram (EEG), event related potentials (ERP) data, and behavior parameters in ADD/ADHD children that not take stimulants or other drugs during study. They would only follow some nutritional recommendations based on increasing the amount of dietary protein and fast carbohydrates decrease. The duration of the study will be 6 months, 3 months for recruitment and 3 months for dietary treatment.
Study Type  ICMJE Interventional
Study Phase  ICMJE Early Phase 1
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Supportive Care
Condition  ICMJE
  • ADD
  • ADHD
Intervention  ICMJE
  • Drug: BP22042013
    This group of patients receive 2.000 kilo-calories diet (60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
    Other Name: Brain Proteins Supplements
  • Dietary Supplement: Low carbohydrate diet
    the second group of patients receive diet of 2.000 Kilo-calories without rapidly absorbed carbohydrates and without proteins supplements
    Other Name: 2000 Kilo-calories without Fast Absorbing Carbohydrate
Study Arms  ICMJE
  • Experimental: BP22042013
    This group of patients receive 2.000 kilocalories diet(60 g. carbohydrates, 144 gr of fat and 107 gr of proteins), including 2 protein shakes.
    Intervention: Drug: BP22042013
  • Experimental: Low carbohydrate Diet
    the second group of patients receive diet of 2.000 Kilo calories without rapidly absorbed carbohydrates and without proteins supplements
    Intervention: Dietary Supplement: Low carbohydrate diet
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Estimated Enrollment  ICMJE
 (submitted: November 21, 2015)
100
Original Estimated Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE November 2015
Actual Primary Completion Date November 2015   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • ADHD diagnosed 12 months before
  • no take medication
  • BMI above the 25th percentile
  • Wiesel score between 80 and 100 (about 120)
  • Patients who agree to participate and whose guardians signed the informed consent form

Exclusion Criteria:

  • eating disorders
  • psychosis, bipolar disorder or depression
  • kidney or liver failure
  • diabetes
  • diuretic or cortisone treatment
  • haematological problems
  • suprarenal diseases
  • cancer
  • Brain injury
  • Cardiovascular or arrhythmia problems
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 7 Years to 13 Years   (Child)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Not Provided
Removed Location Countries Spain
 
Administrative Information
NCT Number  ICMJE NCT02614599
Other Study ID Numbers  ICMJE BrainProteins
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Spanish Foundation for Neurometrics Development
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Spanish Foundation for Neurometrics Development
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE
  • PronoKal Foundation
  • Child Health Foundation
Investigators  ICMJE Not Provided
PRS Account Spanish Foundation for Neurometrics Development
Verification Date November 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP